Moo, T., & Morrow, M. (2018). ASO Author Reflections: Low-Volume Sentinel Node Disease after Neoadjuvant Chemotherapy Is Still an Indication for Axillary Dissection. Ann Surg Oncol.
Chicago Style CitationMoo, Tracy-Ann, i Monica Morrow. "ASO Author Reflections: Low-Volume Sentinel Node Disease After Neoadjuvant Chemotherapy Is Still an Indication for Axillary Dissection." Ann Surg Oncol 2018.
Cita MLAMoo, Tracy-Ann, i Monica Morrow. "ASO Author Reflections: Low-Volume Sentinel Node Disease After Neoadjuvant Chemotherapy Is Still an Indication for Axillary Dissection." Ann Surg Oncol 2018.
Atenció: Aquestes cites poden no estar 100% correctes.